Johnson & Johnson Opens Condition-of-the-Art Science and Technology Campus in San Francisco Bay Space

BRISBANE, Calif., September 20, 2022 – Johnson & Johnson (NYSE: JNJ) (the Firm) nowadays opened its San Francisco Bay Campus, a state-of-the-artwork Study & Enhancement (R&D) facility in the Bay Area, just one of the world’s most founded worldwide hubs for innovation and entrepreneurship. The almost 200,000 sq.-foot facility will household up to 400 employees, additional than doubling the R&D presence of Johnson & Johnson in the Bay Spot. The campus bridges vital scientific and technological abilities by co-locating Janssen R&D, Johnson & Johnson Innovation and Johnson & Johnson Technological know-how. It will more combine the Organization into the Bay Location innovation ecosystem to improve and raise collaborations with innovators to speed up development.

“Johnson & Johnson’s expanded presence in the Bay Space affirms our dedication to combining science and technologies to deliver transformative healthcare alternatives,” claimed Joaquin Duato, Chief Government Officer, Johnson & Johnson. “On this campus, our talented teams will use their varied working experience and know-how to deal with society’s biggest overall health difficulties to create a better long run for individuals.”

The R&D target at the new site spans Janssen’s therapeutic locations and important capabilities, which includes emerging science and systems for gene and RNA therapies, novel treatments and ways for retinal and infectious conditions, and advanced info science, which includes synthetic intelligence and equipment discovering. Co-locating abilities at the site will permit the enlargement of the Company’s planet-class discovery engine and sector-foremost pipeline.

“Our new condition-of-the-art science facility in the Bay Spot will further bolster our R&D capabilities and transform how we discover, establish and supply revolutionary medicines faster and far more proficiently. By integrating drug discovery, facts science and electronic overall health, we intention to speed up the development of our finest-in-class portfolio and deliver far better wellness outcomes for people globally,” claimed James Merson, Ph.D., Internet site Head, San Francisco Bay Campus and World Therapeutic Space Head, Infectious Ailments, Janssen Study & Enhancement, LLC.

The Johnson & Johnson Innovation Centre in California has facilitated investments and collaborations to speed up early-phase healthcare innovation with educational and business companions in the Bay Location and better California ecosystem given that 2014. The San Francisco Bay Campus, alongside with the Company’s JLABS @ South San Francisco, will continue to empower the Corporation to create powerful associations with business owners, experts and buyers to assistance and commit in hugely differentiated innovations that extend and make improvements to lives all over the place. In addition, offered the convergence of healthcare and know-how in the region, the Organization will boost its emphasis on the Johnson & Johnson Technological know-how group to increase its skill to create ground breaking digital options to advance human well being.

Creating on Johnson & Johnson’s very long-standing motivation to use its skills and sources to minimize the environmental footprint of its operations, the Bay Place hub is built as a large-effectiveness environmentally friendly campus, reinforcing the Company’s pledge to be dependable stewards in producing a healthy, additional sustainable future. The intention is for the new web-site to receive Silver Leadership in Electrical power & Environmental Layout (LEED) certification, the most widely utilized eco-friendly constructing rating process in the globe.

About Johnson & Johnson
At Johnson & Johnson, we think great well being is the foundation of vibrant lives, flourishing communities and ahead progress. That is why for far more than 135 yrs, we have aimed to preserve folks very well at every single age and every stage of daily life. Right now, as the world’s biggest and most broadly-primarily based healthcare business, we are fully commited to using our attain and dimensions for very good. We strive to improve obtain and affordability, create much healthier communities, and set a healthful intellect, system and ecosystem within just arrive at of every person, almost everywhere. We are mixing our coronary heart, science and ingenuity to profoundly adjust the trajectory of health for humanity. Study much more at www.jnj.com. Follow us at @JNJNews.

About the Janssen Pharmaceutical Providers of Johnson & Johnson
At Janssen, we are generating a long term in which sickness is a factor of the previous. We are the Pharmaceutical Organizations of Johnson & Johnson, operating tirelessly to make that future a fact for patients everywhere by battling sickness with science, enhancing accessibility with ingenuity, and healing hopelessness with coronary heart. We target on spots of medicine exactly where we can make the major change: Cardiovascular, Metabolism & Retina Immunology Infectious Diseases & Vaccines Neuroscience Oncology and Pulmonary Hypertension. Understand far more at www.janssen.com. Comply with us at @JanssenGlobal. Janssen Investigate & Improvement, LLC is component of the Janssen Pharmaceutical Firms of Johnson & Johnson.

About Johnson & Johnson Innovation
Johnson & Johnson Innovation LLC works throughout the pharmaceutical, clinical product and shopper health sectors to accelerate early-phase, transformational methods by catalyzing the ideal concepts, where ever they are in the planet. We do this by harnessing our deep scientific abilities coupled with a large assortment of instruments, which include custom-made deal constructions, corporation creation, incubation and startup products and services, funds investments and other modern small business versions that purpose to satisfy the varied wants of business owners, researchers, and rising corporations. Our objective is to enable existence science and overall health engineering improvements prosper via collaboration and partnership with the world ecosystem, so that alongside one another we can transform the trajectory of human health. Meet up with our passionate group of science and engineering gurus and understand how to collaborate with us at www.jnjinnovation.com.

About Johnson & Johnson Know-how
Johnson & Johnson Technologies solves major issues in health care through technological know-how and digital innovation. Just as medical practitioners use scalpels, we use facts science, algorithms, artificial intelligence, robotics, and other electronic alternatives to change patients’ lives. From guiding clients as a result of treatment method to accelerating vaccine improvement to enabling staff to get the job done seamlessly from any site, our digital resources infuse our products with novelty, dexterity, and relieve. Guided by Our Credo, we unleash the ability of technologies for fantastic to travel increased entry, equity, and sustainability, and to shape the foreseeable future of health care in the way that only we can.

Cautions Concerning Ahead-Wanting Statements
This push launch incorporates “forward-wanting statements” as outlined in the Private Securities Litigation Reform Act of 1995 pertaining to, among other factors: long term working and financial overall performance, product or service growth, current market position and enterprise method. The reader is cautioned not to count on these ahead-hunting statements. These statements are dependent on existing anticipations of foreseeable future occasions. If underlying assumptions prove inaccurate or acknowledged or mysterious challenges or uncertainties materialize, true final results could differ materially from the anticipations and projections of Janssen Investigation & Progress, LLC. Hazards and uncertainties incorporate, but are not restricted to: financial factors, these as desire fee and currency exchange price fluctuations levels of competition, together with technological improvements, new merchandise and patents attained by competitors difficulties inherent in new products analysis and advancement, such as uncertainty of scientific good results and getting regulatory approvals uncertainty of professional achievements for new and existing solutions challenges to patents the affect of patent expirations the capacity of the Firm to successfully execute strategic options the impact of organization mixtures and divestitures manufacturing complications or delays, internally or in just the offer chain solution efficacy or basic safety issues ensuing in item recalls or regulatory action considerable adverse litigation or federal government motion, like connected to solution liability promises changes to applicable guidelines and laws, which include tax laws and worldwide health care reforms trends towards healthcare value containment alterations in conduct and paying out styles of purchasers of health care items and services economical instability of worldwide economies and legal programs and sovereign risk enhanced scrutiny of the health care field by govt businesses the Company’s capability to fulfill the necessary problems to consummate the separation of the Firm’s Consumer Health and fitness business enterprise on a timely basis or at all the Company’s ability to effectively independent the Firm’s Client Well being organization and recognize the anticipated positive aspects from the separation the New Shopper Well being Company’s capacity to realize success as a standalone publicly traded organization and threats linked to the effect of the COVID-19 world-wide pandemic, these types of as the scope and length of the outbreak, government actions and restrictive steps executed in response, content delays and cancellations of healthcare treatments, provide chain disruptions and other impacts to the business enterprise, or on the Company’s means to execute enterprise continuity strategies as a consequence of the COVID-19 pandemic. A more list and descriptions of these challenges, uncertainties and other variables can be located in Johnson & Johnson’s Yearly Report on Variety 10-K for the fiscal 12 months ended January 2, 2022, which includes in the sections captioned “Cautionary Be aware Pertaining to Forward-Wanting Statements” and “Item 1A. Threat Factors,” and in Johnson & Johnson’s subsequent Quarterly Stories on Type 10-Q and other filings with the Securities and Trade Fee. Copies of these filings are obtainable online at www.sec.gov, www.jnj.com or on ask for from Johnson & Johnson. Any forward-hunting statement produced in this launch speaks only as of the date of this release. Johnson & Johnson does not undertake to update any forward-seeking assertion as a end result of new details or future gatherings or developments.

###